Compare PBH & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBH | DX |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | United States | United States |
| Employees | N/A | 28 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2004 | N/A |
| Metric | PBH | DX |
|---|---|---|
| Price | $47.72 | $12.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $75.33 | $14.75 |
| AVG Volume (30 Days) | 714.8K | ★ 4.4M |
| Earning Date | 05-08-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 15.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.91 | N/A |
| Revenue | ★ $975,777,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.31 | N/A |
| P/E Ratio | $17.31 | ★ $5.66 |
| Revenue Growth | ★ 36.77 | N/A |
| 52 Week Low | $42.62 | $11.76 |
| 52 Week High | $87.09 | $14.93 |
| Indicator | PBH | DX |
|---|---|---|
| Relative Strength Index (RSI) | 33.79 | 34.74 |
| Support Level | $42.62 | $12.25 |
| Resistance Level | $62.91 | $13.04 |
| Average True Range (ATR) | 2.39 | 0.18 |
| MACD | -0.27 | -0.07 |
| Stochastic Oscillator | 36.55 | 17.78 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Dynex Capital Inc is a real estate investment trust (REIT) focused on delivering dividends supported by long term returns from investments in mortgage assets backed by U.S. housing and commercial real estate. The Company is internally managed and mainly invests in residential and commercial mortgage-backed securities (RMBS and CMBS), which are Agency securities guaranteed by U.S. government-sponsored enterprises (GSEs). It manages interest rate, prepayment, spread, liquidity, and counterparty risks and operates through one reportable segment investing in MBS funded with repurchase agreements and equity.